EU suspends imports of certain animal products from Brazil

58174
©

As of 3 September 2026, Brazil is no longer authorised to export a number of animals and animal products intended for human consumption to the European Union. The reason is that the country was not included in the updated list of third countries that have demonstrated compliance with EU requirements concerning the use of certain antimicrobial medicinal products. The restrictions affect, among other products, beef, poultry meat, eggs, honey and casings.

The new rules took effect under European Commission Implementing Regulation (EU) 2026/1189, which amends Regulation (EU) 2021/405 and establishes an updated list of countries authorised to export the relevant products to the EU market.

To be included on this list, third countries must provide the European Commission with evidence and guarantees that animals and products intended for the European market comply with restrictions set out in EU legislation.

In particular, such products must not come from animals treated with antimicrobial medicinal products for growth promotion or to increase yield, or with medicinal products containing antimicrobials reserved in the EU for the treatment of certain infections in humans.

Which Products Are Affected

Brazil is currently not included in the new list of authorised countries. As a result, EU imports of product categories for which the country was previously authorised have been suspended.

The restrictions apply to:

  • beef;
  • poultry meat;
  • horse meat;
  • aquaculture products;
  • eggs;
  • honey;
  • casings.

However, the decision is not necessarily final. If Brazil provides the necessary evidence and guarantees demonstrating compliance with EU requirements, the list of authorised third countries may be revised and trade may resume.

Audit Underway for Poultry and Honey

In late August, the EU launched an audit of Brazil’s control system for poultry meat and honey. The results are expected to determine whether production complies with European requirements and whether Brazil’s status can be reconsidered.

The restrictions form part of the European Union’s broader policy to reduce the use of certain antimicrobial medicinal products and combat antimicrobial resistance (AMR).

The EU aims to apply requirements to imported products that are equivalent to the restrictions already in force for producers within the European Union.


PigUA.info, based on materials from 3tres3.com

comments powered by Disqus